The Spring 2018 DSSG Digest was published at last Friday’s Spring DSSG meeting. It has the most up to date news and listing of cancer trials underway in Ireland. You can download a copy by clicking on the ‘read more’ link below. DSSG Digest Spring 2018

IWD 2018

On International Women’s Day 2018 we salute and celebrate all women in research and a give special shout out to all the heroic women on cancer trials around the country and around the world – thank you.

BioPharma Ambition

We were delighted to have been part the important discussion on unblocking the potential of collaboration at this year’s BioPharma Ambition. Session participants included (l to r) Dr Muhammed Ali, Executive Director, Regional Healthcare Solutions Strategy, MSD International; Dr Richard L. Schilsky, Senior Vice PresidenWe were delighted to have been part the important discussion on […]

Minister Meeting

A delegation from Cancer Trials Ireland met recently with Simon Harris TD, Minister for Health, and Dr Jerome Coffey, Director of the NCCP, to discuss implementing the National Cancer Strategy, the opportunities to develop further Ireland’s expertise in cancer trials and financial challenges. Pictured (l to r) Dr Jerome Coffey, Director of the NCCP, Simon […]

EAPM Congress and all-island trial collaboration

Following our work with InterTrade Ireland to promote all-island cancer trial collaboration our Clinical Lead, Prof Bryan Hennessy, will be co-chairing the session “Discover What’s Possible – The opportunities and challenges of all-island cancer clinical trial collaboration” at EAPM’s first major European Personalised Medicine Congress which will be hosted in Belfast next week (27-30 Nov) Check […]

Just published in Lancet Oncology

The findings of the SOLE trial have just been published in Lancet Oncology with Dr Seamus O’Reilly, consultant medical oncologist at Cork-Mercy and South Infirmary Victoria University Hospitals as one of the authors.  Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial In […]